PE232000: β-GlcNAc-PEG3-Acid Pack Size:10 mg 5-Bis(trifluoromethyl)phenyl]ethoxy]-3- (4-fluorophenyl)-4-morpholinyl]methyl]-1

5-Bis(trifluoromethyl)phenyl]ethoxy]-3- (4-fluorophenyl)-4-morpholinyl]methyl]-1

/ β-D-GalNAc-Ethyl-Azide (Peracetate) / β-GalNAc(Ac)3-Et-N3

N/A / N/A / A Galα1-3lactose (α-Gal epitope) ligand equipped with a maleimide through an NHCO-PEG10 spacer

The Nα-Fmoc group is removed under standard base conditions (piperidine) during chain elongation

β-D-Gal-Bu-CO2H

PE232000: β-GlcNAc-PEG3-Acid Pack Size:10 mg 5-Bis(trifluoromethyl)phenyl]ethoxy]-3- (4-fluorophenyl)-4-morpholinyl]methyl]-1C15H27NO10 381. 38 A D N acetylglucosamine (GlcNAc) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG3 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound provides a N acetylglucosamine (GlcNAc) building block for glycoconjugate synthesis and the construction of